{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:49:27Z","timestamp":1787964567178,"version":"build-2784847793"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01308","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T06:03:25Z","timestamp":1599545005000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Pushpendra","family":"Goswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther N.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Ionova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele K.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Karakantza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Al-Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Langton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda J.","family":"Al-Obaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metod","family":"Oblak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/bcj.2015.29","article-title":"Haematological cancer and quality of life: a systematic literature review","volume":"5","author":"Allart-Vorelli","year":"2015","journal-title":"Blood Cancer J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1586\/erp.09.23","article-title":"Burden of skin diseases","volume":"9","author":"Basra","year":"2009","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.jval.2012.08.2210","article-title":"Measuring health-related quality of life in leukemia: the Functional Assessment of Cancer Therapy\u2013Leukemia (FACT-Leu) questionnaire","volume":"15","author":"Cella","year":"2012","journal-title":"Value Health"},{"key":"B6","volume-title":"Scale Development: Theory and Applications","author":"DeVellis","year":"2016"},{"key":"B7","volume-title":"Mail and Internet Surveys: The Tailored Design Method - 2007 Update with New Internet, Visual, and Mixed-Mode Guide","author":"Dillman","year":"2006"},{"key":"B8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1182\/blood-2017-03-737403","article-title":"Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice","volume":"130","author":"Efficace","year":"2017","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/ejh.13104","article-title":"Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantation","volume":"101","author":"Esser","year":"2018","journal-title":"Eur. J. Haematol."},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1002\/9780470024522","volume-title":"Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes","author":"Fayers","year":"2007"},{"key":"B11","volume-title":"Quality of Life: The Assessment, Analysis and Interpretation of Patient-reported Outcomes","author":"Fayers","year":"2013"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.1182\/blood.V128.22.5985.5985","article-title":"Development of a Novel Patient-Reported Outcome Measure in Haematological Malignancy for Use in Routine Clinical Practice: Item Generation","volume":"128","author":"Goswami","year":"2016","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood.V130.Suppl_1.2176.2176","article-title":"HM-PRO: A Novel Patient-Reported Outcome Measure in Hematological Malignancy for Use in Clinical Practice","volume":"130","author":"Goswami","year":"2017","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1182\/blood-2018-99-117094","article-title":"Responsiveness and the Minimal Clinically Important Difference for HM-PRO in Patients with Hematological Malignancies","volume":"132","author":"Goswami","year":"2018","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4860","DOI":"10.1182\/blood-2018-99-117180","article-title":"Translating the Science of Patient Reported Outcomes into Practice: Meaningfulness of HM-PRO Scores in Patients with Hematological Malignancies","volume":"132","author":"Goswami","year":"2018","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ejh.13203","article-title":"Haematological malignancy: Are we measuring what is important to patients? A systematic review of quality-of-life instruments","volume":"102","author":"Goswami","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/cer-2018-0108","article-title":"Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study","volume":"8","author":"Goswami","year":"2019","journal-title":"J. Comp. Eff. Res."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00209","article-title":"Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity","volume":"11","author":"Goswami","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2013\/147176","article-title":"The Development and Validation of a Measure of Health-Related Quality of Life for Non-Hodgkin's Lymphoma: The Functional Assessment of Cancer Therapy\u2014Lymphoma (FACT-Lym)","volume":"2013","author":"Hlubocky","year":"2013","journal-title":"Lymphoma"},{"key":"B20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1191\/0269216303pm841oa","article-title":"The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors","volume":"17","author":"Knobel","year":"2003","journal-title":"Palliat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"110s","DOI":"10.1378\/chest.109.5_Supplement.110S","article-title":"Quality of life as a new end point","volume":"109","author":"Kosmidis","year":"1996","journal-title":"Chest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-8-79","article-title":"Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma","volume":"8","author":"Kvam","year":"2010","journal-title":"Health Qual. Life Outcomes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1600-0609.2011.01665.x","article-title":"Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma","volume":"87","author":"Kvam","year":"2011","journal-title":"Eur. J. Haematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/sj.bmt.1700672","article-title":"Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale","volume":"19","author":"McQuellon","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"B25","first-page":"33","article-title":"The once and future issues of validity: Assessing the meaning and consequences of measurement","author":"Messick","year":"1988"},{"key":"B26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1037\/0003-066X.50.9.741","article-title":"Validity of Psychological Assessment: Validation ofInferences from Persons\u2019 Responses and Performancesas Scientific Inquiry into Score Meaning","volume":"50","author":"Messick","year":"1994","journal-title":"Am. Psychol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2307\/1267425","article-title":"The Use of an F-Statistic in Stepwise Regression Procedures","volume":"14","author":"Pope","year":"1972","journal-title":"Technometrics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7748\/ns.20.36.41.s58","article-title":"Reliability and validity in research","volume":"20","author":"Roberts","year":"2006","journal-title":"Nurs. Stand."},{"key":"B30","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199685219.001.0001","volume-title":"Health Measurement Scales: A Practical Guide To Their Development and Use (5th ed.)","author":"Streiner","year":"2015"},{"key":"B31","volume-title":"Evidenced-Based Health Care Management. Multivariate Modeling Approaches","author":"Wan","year":"2002"},{"key":"B32","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/10428194.2012.711830","article-title":"The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma","volume":"54","author":"Yost","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"B33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15171\/jcs.2015.017","article-title":"Design and Implementation Content Validity Study: Development of an instrument for measuring Patient-Centered Communication","volume":"4","author":"Zamanzadeh","year":"2015","journal-title":"J. Caring Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01308\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T06:03:29Z","timestamp":1599545009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01308\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":33,"alternative-id":["10.3389\/fphar.2020.01308"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01308","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]},"article-number":"1308"}}